Welnfuse, an Austin, TX-based provider of software and technology platform for infusion therapy and medication delivery in the U.S., received a Growth investment from Curewell Capital.
The amount of the deal was not disclosed.
The company intends to use the funds for its continued expansion and strategic initiatives.
Led by CEO Bryan Johnson, Welnfuse is a software and technology provider for infusion therapy and medication delivery in the U.S. The company’s software platform, which currently powers over 625 infusion centers across the country, has expanded its platform to include a home infusion and specialty pharmacy workflow, as well as a reporting and analytics engine.
As part of the investment, Michael Dal Bello and Ceron Rhee, Partners at Curewell Capital, and George Lazenby, Curewell Senior Advisor and CEO of OrderInsite, will be joining WeInfuse’s board of directors and help lead ITAC.
FinSMEs
02/03/2023